scispace - formally typeset
Journal ArticleDOI

Computational investigation of curcumin, a natural polyphenol that inhibits the destabilization and the aggregation of human SOD1 mutant (Ala4Val)

E. Srinivasan, +1 more
- 26 Oct 2016 - 
- Vol. 6, Iss: 104, pp 102744-102753
TLDR
The study postulated a classical treatment against mutant SOD1, using the naturally occurring polyphenol (curcumin) via the computational framework for designing therapeutics against ALS, and suggested that curcumin showed an enhanced binding affinity in the mutant Sod1 with increased hydrophobic interactions as compared to native S OD1.
Abstract
Aberrant aggregation in proteins leads to increased propensity of β-sheets, thereby increasing the toxicity level Numerous neurological disorders are triggered due to aggregation in protein Superoxide dismutase 1 (SOD1) is one such protein that leads to familial amyotrophic lateral sclerosis, a devastating neurodegenerative disorder In our study, the aggregation effect in native and the fatal mutant (Ala4Val) SOD1 was examined, using tCONCOORD Experimental studies reported that the naturally obtained polyphenol has an inhibitory effect on the aggregated protein Consequently, we predominantly focused on curcumin, a natural occurring polyphenol, to inhibit the aggregation in SOD1 In view of that, curcumin was computationally docked with both the native and mutant SOD1, using Autodock Thus, our analysis suggested that curcumin showed an enhanced binding affinity in the mutant SOD1 with increased hydrophobic interactions as compared to native SOD1 Further investigations were accomplished, using steered molecular dynamics and conformational sampling on both the bound complexes of native and mutant SOD1 with curcumin to unravel the effect of disaggregation In addition, we also elucidated the variations in the free energy landscape of native and mutant SOD1 in their unbound and bound states to differentiate the aggregation Hence, the study postulated a classical treatment against mutant SOD1, using the naturally occurring polyphenol (curcumin) via the computational framework for designing therapeutics against ALS

read more

Citations
More filters
Journal ArticleDOI

Amyloid oligomers: A joint experimental/computational perspective on Alzheimer's disease, Parkinson's disease, type II diabetes, and amyotrophic lateral sclerosis

TL;DR: In this paper, the authors review what computer, in vitro, in vivo, and pharmacological experiments tell us about the accumulation and deposition of the oligomers of the (Aβ, tau), α-synuclein, IAPP, and superoxide dismutase 1 proteins, which have been the mainstream concept underlying Alzheimer's disease, Parkinson's disease (PD), type II diabetes (T2D), and amyotrophic lateral sclerosis (ALS) research.
Journal ArticleDOI

Advances in Applying Computer-Aided Drug Design for Neurodegenerative Diseases

TL;DR: In this paper, the authors provide an overview of potential therapeutic targets for various neurodegenerative diseases (NDs) and discuss some of the advantages and disadvantages of computer-aided drug design (CADD) methods.
Journal ArticleDOI

In Silico Studies in Drug Research Against Neurodegenerative Diseases.

TL;DR: Neurodegenerative diseases have a multifactorial pathoetiological origin, so scientists have become persuaded that a multi-target therapeutic strategy aimed at the simultaneous targeting of multiple proteins involved in the development of a disease is recommended in future.
Journal ArticleDOI

Structural and Dynamic Characterizations Highlight the Deleterious Role of SULT1A1 R213H Polymorphism in Substrate Binding.

TL;DR: The dynamics scenario of SULT1A1 in both wild and mutated types as well as with and without ligand showed that R213H induced local conformational changes, especially in the substrate-binding loop rather than impairing overall stability of the protein structure.
Journal ArticleDOI

Structure-based identification of potent VEGFR-2 inhibitors from in vivo metabolites of a herbal ingredient.

TL;DR: Two virtual hits are uncovered as VEGFR-2 inhibitors, and it is suggested that they bind to kinase domain in an ATP-competitive manner, allowing a rational search for more effective inhibitors in the future.
References
More filters
Journal ArticleDOI

Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems

TL;DR: An N⋅log(N) method for evaluating electrostatic energies and forces of large periodic systems is presented based on interpolation of the reciprocal space Ewald sums and evaluation of the resulting convolutions using fast Fourier transforms.
Journal ArticleDOI

AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility

TL;DR: AutoDock4 incorporates limited flexibility in the receptor and its utility in analysis of covalently bound ligands is reported, using both a grid‐based docking method and a modification of the flexible sidechain technique.
Journal ArticleDOI

GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation

TL;DR: A new implementation of the molecular simulation toolkit GROMACS is presented which now both achieves extremely high performance on single processors from algorithmic optimizations and hand-coded routines and simultaneously scales very well on parallel machines.
Journal ArticleDOI

Development and testing of a general amber force field.

TL;DR: A general Amber force field for organic molecules is described, designed to be compatible with existing Amber force fields for proteins and nucleic acids, and has parameters for most organic and pharmaceutical molecules that are composed of H, C, N, O, S, P, and halogens.
Journal ArticleDOI

g_mmpbsa--a GROMACS tool for high-throughput MM-PBSA calculations.

TL;DR: A new tool, g_mmpbsa, which implements the MM-PBSA approach using subroutines written in-house or sourced from the GROMACS and APBS packages is described, and the calculated interaction energy of 37 structurally diverse HIV-1 protease inhibitor complexes is compared.
Related Papers (5)